Abstract
We aimed to improve the microbial diagnosis of first episodes of febrile neutropenia (FEFNs) since 2 = 0.67, P = 0.41). Direct DNA detection was positive in nine episodes (7.5%) that were also positive in BC. The new workflow provided microbiological results significantly earlier than the standard workflow, with a shorter time to BC positivity (median 12 h 31 min, range 7 h 55 min–25 h 37 min versus median 13 h 01 min, range 9 h 31 min–43 h 33 min, P = 0.004) and shorter turnaround times for identification and susceptibility testing, with most of the results obtained <24 h after BC sampling. We retrospectively estimated that the new workflow would lead to earlier adequacy of antimicrobial therapy in 30% of documented cases. Our new process improved the microbiological diagnosis in FEFNs. Cost effectiveness needs to be tested.

This publication has 17 references indexed in Scilit: